Silence Therapeutics (SLN) Prepaid Assets (2018 - 2026)
Silence Therapeutics (SLN) reported Prepaid Assets of $10.6 million for Q1 2026, down 35.7% on a YoY basis from $16.4 million in Q1 2025, and down 8.49% sequentially from $11.5 million in Q4 2025.
Silence Therapeutics (SLN) Prepaid Assets (2018 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 9 years of Prepaid Assets data on file, last reported at $10.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 35.7% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (down 35.7% YoY), and the FY2025 full-year result was $11.5 million, down 21.32% from the prior year.
- Prepaid Assets slipped to $10.6 million in Q1 2026, from $11.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $16.4 million in Q1 2025 to a low of $9.3 million in Q3 2025.
- A 5-year average of $12.2 million and a median of $11.4 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 65.58% in 2022 and sank 35.7% in 2026, its largest moves.
- Tracing SLN's Prepaid Assets over 5 years: stood at $9.6 million in 2022, then gained by 17.88% to $11.3 million in 2023, then grew by 29.34% to $14.7 million in 2024, then dropped by 21.32% to $11.5 million in 2025, then fell by 8.49% to $10.6 million in 2026.
- Business Quant data shows SLN's Prepaid Assets at $10.6 million in Q1 2026, $11.5 million in Q4 2025, and $9.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.56 Mn |
| Dec 31, 2025 | 11.54 Mn |
| Sep 30, 2025 | 9.26 Mn |
| Jun 30, 2025 | 14.36 Mn |
| Mar 31, 2025 | 16.42 Mn |
| Dec 31, 2024 | 14.66 Mn |
| Dec 31, 2023 | 11.34 Mn |
| Dec 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 5.81 Mn |
| Dec 31, 2020 | 6.10 Mn |
| Dec 31, 2019 | 554,147.43 |
| Dec 31, 2018 | 1.13 Mn |